ClinicalTrials.Veeva

Menu
B

Benchmark Research | Austin, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

MF101
Lorcaserin Hydrochloride
Tecovirimat
Famciclovir
NB-001
KYG0395
Pilocarpine
Ciclesonide
Estradiol
NVX-Cov2373

Parent organization

This site is a part of Benchmark Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 64 total trials
Status recently updated

A Strain Change Study for SARS-CoV-2 rS Vaccines (COVID-19)

The present study aims to investigate the safety and immunogenicity of the Novavax JN.1 subvariant vaccine SARS-CoV-2 rS adjuvanted with Matrix-M (NV...

Not yet enrolling
Active, not recruiting
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Biological: NVX-CoV2705 Vaccine

The purpose of this study is to evaluate the safety and reactogenicity of mRNA-1195 in healthy adults (18 to 55 years of age).

Active, not recruiting
Epstein-Barr Virus Infection
Biological: Placebo
Biological: mRNA-1195.2

The main goal of this study is to evaluate the safety, reactogenicity, and immunogenicity of study vaccines.

Active, not recruiting
Respiratory Syncytial Virus
Seasonal Influenza
Biological: FLUAD®
Biological: mRNA-1647

The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...

Active, not recruiting
COVID-19
Biological: mRNA-1283.222
Biological: mRNA-1273.815

The study is divided into 2 parts: Part 1 and Part 2. The purpose of Part 1 of this study is to generate sufficient safety, reactogenicity, and immun...

Active, not recruiting
Influenza
SARS-CoV-2
Biological: Investigational Influenza Vaccine 1
Biological: COVID-19 Vaccine 2

The primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1403, and to demonstrate the efficacy of mRNA-1403 to prev...

Enrolling
Acute Gastroenteritis
Norovirus Acute Gastroenteritis
Biological: mRNA-1403
Biological: Placebo

This study is to understand if the study vaccine (called VLA15) is safe in healthy children.We are looking for children who:* are healthy* are age 5...

Active, not recruiting
Lyme Disease
Other: Normal Saline
Biological: VLA15

This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity an...

Active, not recruiting
SARS-CoV-2 Infection
Biological: Intramuscular vaccine
Drug: Intramuscular injection

Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of a...

Enrolling
Lower Respiratory Tract Illness
Biological: RSVpreF
Biological: Placebo

An antibody is a substance your body makes to fight off infection. This study will explore the safety and antibody response of a vaccine to prevent s...

Active, not recruiting
Clostridoides Difficile Associated Disease
Biological: C. difficile vaccine formulation 1.
Other: Saline Placebo.

Trial sponsors

Pfizer logo
Moderna logo
Novavax logo
BioNTech logo
MedImmune logo
Merck Sharp & Dohme (MSD) logo
A
B
C
I

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems